Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
Status:
Withdrawn
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as temozolomide and topotecan, work in different
ways to stop the growth of cancer cells, either by killing the cells or by stopping them from
dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells.
PURPOSE: This phase II trial is studying how well giving temozolomide together with topotecan
works in treating patients with primary CNS lymphoma.
Phase:
N/A
Details
Lead Sponsor:
The Methodist Hospital Research Institute The Methodist Hospital System